Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Neal, DAJ; Gimson, AES; Gibbs, P; Alexander, GJM
   Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight
   LIVER TRANSPLANTATION
   
   D.A.J. Neal et al., "Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight", LIVER TRANS, 7(6), 2001, pp. 533-539
2. Yu, LB; Zhang, RZ; Wang, ZQ
   A new and efficient route to derivatives of (R)-4-hydroxycyclohex-2-enone
   JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1
   
   L.B. Yu et al., "A new and efficient route to derivatives of (R)-4-hydroxycyclohex-2-enone", J CHEM S P1, (22), 2001, pp. 2958-2961
3. Dmitrewski, J; Krentz, AJ; Mayer, AD; Buckels, JAC; Barnes, AD; Smith, J; Nattrass, M
   Metabolic and hormonal effects of tacrolimus (FK506) or cyclosporin immunosuppression following renal transplantation
   DIABETES OBESITY & METABOLISM
   
   J. Dmitrewski et al., "Metabolic and hormonal effects of tacrolimus (FK506) or cyclosporin immunosuppression following renal transplantation", DIABET OB M, 3(4), 2001, pp. 287-292
4. Sano, N; Nio, M; Shimaoka, S; Ishii, T; Amae, S; Wada, M; Ohi, R
   High trough levels of oral FK506 induced by loss of small intestine
   PEDIATRIC TRANSPLANTATION
   
   N. Sano et al., "High trough levels of oral FK506 induced by loss of small intestine", PEDIAT TRAN, 5(6), 2001, pp. 434-438
5. Flynn, JT; Bunchman, TE; Sherbotie, JR
   Indications, results, and complications of tacrolimus conversion in pediatric renal transplantation
   PEDIATRIC TRANSPLANTATION
   
   J.T. Flynn et al., "Indications, results, and complications of tacrolimus conversion in pediatric renal transplantation", PEDIAT TRAN, 5(6), 2001, pp. 439-446
6. Cacciarelli, TV; Reyes, J; Jaffe, R; Mazariegos, GV; Jain, A; Fung, JJ; Green, M
   Primary tacrolimus (FK506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients
   PEDIATRIC TRANSPLANTATION
   
   T.V. Cacciarelli et al., "Primary tacrolimus (FK506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients", PEDIAT TRAN, 5(5), 2001, pp. 359-364
7. Papalois, VE; Najarian, JS
   Pediatric kidney transplantation: Historic hallmarks and a personal perspective
   PEDIATRIC TRANSPLANTATION
   
   V.E. Papalois e J.S. Najarian, "Pediatric kidney transplantation: Historic hallmarks and a personal perspective", PEDIAT TRAN, 5(4), 2001, pp. 239-245
8. MacFarlane, GD; Venkataramanan, R; McDiarmid, SV; Pirsch, JD; Scheller, DG; Ersfeld, DL; Fitzsimmons, WE
   Therapeutic drug monitoring of tacrolimus in pediatric liver transplant patients
   PEDIATRIC TRANSPLANTATION
   
   G.D. MacFarlane et al., "Therapeutic drug monitoring of tacrolimus in pediatric liver transplant patients", PEDIAT TRAN, 5(2), 2001, pp. 119-124
9. Fruhwirth, M; Fischer, H; Simma, B; Ellemunter, H
   Elevated tacrolimus trough levels in association with mycophenolate mofetil-induced diarrhea: A case report
   PEDIATRIC TRANSPLANTATION
   
   M. Fruhwirth et al., "Elevated tacrolimus trough levels in association with mycophenolate mofetil-induced diarrhea: A case report", PEDIAT TRAN, 5(2), 2001, pp. 132-134
10. Freyschmidt-Paul, P; Ziegler, A; McElwee, KJ; Happle, R; Kissling, S; Sundberg, JP; Hoffmann, R
    Treatment of alopecia areata in C3H/Hej mice with the topical immunosuppressant FK506 (Tacrolimus)
    EUROPEAN JOURNAL OF DERMATOLOGY
    
    P. Freyschmidt-Paul et al., "Treatment of alopecia areata in C3H/Hej mice with the topical immunosuppressant FK506 (Tacrolimus)", EUR J DERM, 11(5), 2001, pp. 405-409
11. Koch, G; Jeck, R; Hartmann, O; Kusters, E
    Selective synthesis of a new ascomycin rearrangement product (SDZ ASD732) on a pilot plant scale
    ORGANIC PROCESS RESEARCH & DEVELOPMENT
    
    G. Koch et al., "Selective synthesis of a new ascomycin rearrangement product (SDZ ASD732) on a pilot plant scale", ORG PROC R, 5(3), 2001, pp. 211-215
12. Lhoest, G; Hertsens, R; Verbeeck, RK; Maton, N; Wallemacq, P; Dehoux, JP; Latinne, D
    In vitro immunosuppressive activity of tacrolimus dihydrodiol precursors obtained by chemical oxidation and identification of a new metabolite of SDZ-RAD by electrospray and electrospray-linked scan mass spectrometry
    JOURNAL OF MASS SPECTROMETRY
    
    G. Lhoest et al., "In vitro immunosuppressive activity of tacrolimus dihydrodiol precursors obtained by chemical oxidation and identification of a new metabolite of SDZ-RAD by electrospray and electrospray-linked scan mass spectrometry", J MASS SPEC, 36(8), 2001, pp. 889-901
13. Koshika, T; Ishizaka, A; Nagatomi, I; Sudo, Y; Hasegawa, N; Goto, T
    Pretreatment with FK506 improves survival rate and gas exchange in canine model of acute lung injury
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    
    T. Koshika et al., "Pretreatment with FK506 improves survival rate and gas exchange in canine model of acute lung injury", AM J R CRIT, 163(1), 2001, pp. 79-84
14. Markell, MS
    Post-transplant diabetes: Incidence, relationship to choice of immunosuppressive drugs, and treatment protocol
    ADVANCES IN RENAL REPLACEMENT THERAPY
    
    M.S. Markell, "Post-transplant diabetes: Incidence, relationship to choice of immunosuppressive drugs, and treatment protocol", ADV RENAL R, 8(1), 2001, pp. 64-69
15. Skaehill, PA
    Tacrolimus in dermatologic disorders
    ANNALS OF PHARMACOTHERAPY
    
    P.A. Skaehill, "Tacrolimus in dermatologic disorders", ANN PHARMAC, 35(5), 2001, pp. 582-588
16. Taylor, DO; Barr, ML; Meiser, BM; Pham, SM; Mentzer, RM; Gass, AL
    Suggested guidelines for the use of tacrolimus in cardiac transplant recipients
    JOURNAL OF HEART AND LUNG TRANSPLANTATION
    
    D.O. Taylor et al., "Suggested guidelines for the use of tacrolimus in cardiac transplant recipients", J HEART LUN, 20(7), 2001, pp. 734-738
17. Sharples, LD; Taylor, GJ; Karnon, J; Caine, N; Buxton, M; McNeil, K; Wallwork, J
    A model for analyzing the cost of the main clinical events after lung transplantation
    JOURNAL OF HEART AND LUNG TRANSPLANTATION
    
    L.D. Sharples et al., "A model for analyzing the cost of the main clinical events after lung transplantation", J HEART LUN, 20(4), 2001, pp. 474-482
18. Baran, DA; Segura, L; Kushwaha, S; Courtney, M; Correa, R; Fallon, JT; Cheng, J; Lansman, SL; Gass, AL
    Tacrolimus monotherapy in adult cardiac transplant recipients: Intermediate-term results
    JOURNAL OF HEART AND LUNG TRANSPLANTATION
    
    D.A. Baran et al., "Tacrolimus monotherapy in adult cardiac transplant recipients: Intermediate-term results", J HEART LUN, 20(1), 2001, pp. 59-70
19. van Duijnhoven, EM; Boots, JMM; Christiaans, MHL; Wolffenbuttel, BHR; Van Hooff, JP
    Influence of tacrolimus on glucose metabolism before and after renal transplantation: A prospective study
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    
    E.M. van Duijnhoven et al., "Influence of tacrolimus on glucose metabolism before and after renal transplantation: A prospective study", J AM S NEPH, 12(3), 2001, pp. 583-588
20. Kawakami, T; Soma, Y; Morita, E; Koro, O; Yamamoto, S; Nakamura, K; Tamaki, K; Yajima, K; Imaizumi, A; Matsunaga, R; Murakami, N; Kashima, M; Mizoguchi, M
    Safe and effective treatment of refractory facial lesions in atopic dermatitis using topical tacrolimus following corticosteroid discontinuation
    DERMATOLOGY
    
    T. Kawakami et al., "Safe and effective treatment of refractory facial lesions in atopic dermatitis using topical tacrolimus following corticosteroid discontinuation", DERMATOLOGY, 203(1), 2001, pp. 32-37
21. De Bonis, M; Reynolds, L; Barros, J; Madden, BP
    Tacrolimus as a rescue immunosuppressant after heart transplantation
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
    
    M. De Bonis et al., "Tacrolimus as a rescue immunosuppressant after heart transplantation", EUR J CAR-T, 19(5), 2001, pp. 690-695
22. Anneser, JMH; Gmerek, A; Gerkrath, J; Borasio, GD; Heumann, R
    Immunosuppressant FK506 does not exert beneficial effects in symptomatic G93A superoxide dismutase-1 transgenic mice
    NEUROREPORT
    
    J.M.H. Anneser et al., "Immunosuppressant FK506 does not exert beneficial effects in symptomatic G93A superoxide dismutase-1 transgenic mice", NEUROREPORT, 12(12), 2001, pp. 2663-2665
23. Miyauchi, T; Ishikawa, M; Tashiro, S
    Evaluation of the acetaminophen absorption test for early detection of orthotopic small bowel transplant rejection
    SURGERY TODAY
    
    T. Miyauchi et al., "Evaluation of the acetaminophen absorption test for early detection of orthotopic small bowel transplant rejection", SURG TODAY, 31(8), 2001, pp. 695-700
24. Wang, LM; Kubodera, S; Araki, I; Takihana, Y; Ueno, A; Takeda, M
    Inhibition of nitric oxide synthase induces intestinal mucosal damage and increases mortality in rats treated by FK506
    EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
    
    L.M. Wang et al., "Inhibition of nitric oxide synthase induces intestinal mucosal damage and increases mortality in rats treated by FK506", EXP TOX PAT, 53(4), 2001, pp. 297-301
25. Staatz, C; Taylor, P; Tett, S
    Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    C. Staatz et al., "Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation", NEPH DIAL T, 16(9), 2001, pp. 1905-1909
26. Dietemann, J; Berthoux, P; Gay-Montchamp, JP; Batie, M; Berthoux, F
    Comparison of ELISA method versus MEIA method for daily practice in the therapeutic monitoring of tacrolimus
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    J. Dietemann et al., "Comparison of ELISA method versus MEIA method for daily practice in the therapeutic monitoring of tacrolimus", NEPH DIAL T, 16(11), 2001, pp. 2246-2249
27. Swiatecka-Urban, A; Garcia, C; Feuerstein, D; Suzuki, S; Devarajan, P; Schechner, R; Greenstein, S; Tellis, V; Kaskel, F
    Basiliximab induction improves the outcome of renal transplants in children and adolescents
    PEDIATRIC NEPHROLOGY
    
    A. Swiatecka-Urban et al., "Basiliximab induction improves the outcome of renal transplants in children and adolescents", PED NEPHROL, 16(9), 2001, pp. 693-696
28. Dello Strologo, L; Pontesilli, C; Montini, G; Ginevri, F; Ardissino, G; Campagnano, P; Pastore, A; Federici, G; Rizzoni, G
    Renal hemodynamic effect of tacrolimus in renal transplanted children
    PEDIATRIC NEPHROLOGY
    
    L. Dello Strologo et al., "Renal hemodynamic effect of tacrolimus in renal transplanted children", PED NEPHROL, 16(10), 2001, pp. 773-776
29. Wakugawa, M; Hayashi, K; Nakamura, K; Tamaki, K
    Evaluation of mite allergen-induced Till and Th2 cytokine secretion of peripheral blood mononuclear cells from atopic dermatitis patients: association between IL-13 and mite-specific IgE levels
    JOURNAL OF DERMATOLOGICAL SCIENCE
    
    M. Wakugawa et al., "Evaluation of mite allergen-induced Till and Th2 cytokine secretion of peripheral blood mononuclear cells from atopic dermatitis patients: association between IL-13 and mite-specific IgE levels", J DERMA SCI, 25(2), 2001, pp. 116-126
30. Satoh, S; Tada, H; Tachiki, Y; Tsuchiya, N; Shimoda, N; Akao, T; Sato, K; Habuchi, T; Suzuki, T; Kato, T
    Chrono and clinical pharmacokinetic study of tacrolimus in continuous intravenous administration
    INTERNATIONAL JOURNAL OF UROLOGY
    
    S. Satoh et al., "Chrono and clinical pharmacokinetic study of tacrolimus in continuous intravenous administration", INT J UROL, 8(7), 2001, pp. 353-358
31. Uyeda, M; Mizukami, M; Yokomizo, K; Suzuki, K
    Pentalenolactone I and hygromycin A, immunosuppressants produced by Streptomyces filipinensis and Streptomyces hygroscopicus
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
    
    M. Uyeda et al., "Pentalenolactone I and hygromycin A, immunosuppressants produced by Streptomyces filipinensis and Streptomyces hygroscopicus", BIOS BIOT B, 65(5), 2001, pp. 1252-1254
32. Kimikawa, M; Kamoya, K; Toma, H; Teraoka, S
    Effective oral administration of tacrolimus in renal transplant recipients
    CLINICAL TRANSPLANTATION
    
    M. Kimikawa et al., "Effective oral administration of tacrolimus in renal transplant recipients", CLIN TRANSP, 15(5), 2001, pp. 324-329
33. Feng, FY; Ogden, MA; Myckatyn, TM; Grand, AG; Jensen, JN; Hunter, DA; Mackinnon, SE
    FK506 rescues peripheral nerve allografts in acute rejection
    JOURNAL OF NEUROTRAUMA
    
    F.Y. Feng et al., "FK506 rescues peripheral nerve allografts in acute rejection", J NEUROTRAU, 18(2), 2001, pp. 217-229
34. Wang, LM; Kubodera, S; Ueno, A; Takeda, M
    Effects of nitric oxide synthesis inhibition on FK506-induced nephrotoxicity in rats
    RENAL FAILURE
    
    L.M. Wang et al., "Effects of nitric oxide synthesis inhibition on FK506-induced nephrotoxicity in rats", RENAL FAIL, 23(1), 2001, pp. 11-19
35. Sotereanos, NG; Varitimidis, SE; Sewecke, JJ; Sotereanos, DG; Demeo, PJ; Berger, RA
    Vascularized orthotopic osteochondral transplantation of the canine proximal femur
    JOURNAL OF RECONSTRUCTIVE MICROSURGERY
    
    N.G. Sotereanos et al., "Vascularized orthotopic osteochondral transplantation of the canine proximal femur", J RECON MIC, 17(2), 2001, pp. 125-131
36. Motohashi, H; Katsura, T; Saito, H; Inui, K
    Effects of tacrolimus and cyclosporin A on peptide transporter PEPT1 in Caco-2 cells
    PHARMACEUTICAL RESEARCH
    
    H. Motohashi et al., "Effects of tacrolimus and cyclosporin A on peptide transporter PEPT1 in Caco-2 cells", PHARM RES, 18(5), 2001, pp. 713-717
37. Letko, E; Ahmed, AR; Foster, CS
    Treatment of ocular cicatricial pemphigoid with tacrolimus (FK 506)
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
    
    E. Letko et al., "Treatment of ocular cicatricial pemphigoid with tacrolimus (FK 506)", GR ARCH CL, 239(6), 2001, pp. 441-444
38. Bassas, AF; Wali, SH; Chehab, MS; Al-Husseini, HF; Al-Shahed, MS; Al-Shuraffa, HA; Jawdat, MT
    Living-related liver transplantation
    SAUDI MEDICAL JOURNAL
    
    A.F. Bassas et al., "Living-related liver transplantation", SAUDI MED J, 22(3), 2001, pp. 276-279
39. Iwasaki, N; Gohda, T; Itoga, H; Minami, A; Kaneda, K
    Effects of major histocompatibility complex matching on graft survival in allogeneic rat limb transplantation
    JOURNAL OF HAND SURGERY-AMERICAN VOLUME
    
    N. Iwasaki et al., "Effects of major histocompatibility complex matching on graft survival in allogeneic rat limb transplantation", J HAND S-AM, 26A(3), 2001, pp. 540-545
40. Filer, CN
    The preparation of isotopically labelled macrocyclic compounds by organic synthesis
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    
    C.N. Filer, "The preparation of isotopically labelled macrocyclic compounds by organic synthesis", J LABEL C R, -4(13), 2001, pp. 931-945
41. Sanchez, MJG; Manzanares, C; Santos-Buelga, D; Blazquez, A; Manzanares, J; Urruzuno, P; Medina, E
    Covariate effects on the apparent clearance of tacrolimus in paediatric liver transplant patients undergoing conversion therapy
    CLINICAL PHARMACOKINETICS
    
    M.J.G. Sanchez et al., "Covariate effects on the apparent clearance of tacrolimus in paediatric liver transplant patients undergoing conversion therapy", CLIN PHARMA, 40(1), 2001, pp. 63-71
42. Ross, DT; Guo, HZ; Howorth, P; Chen, Y; Hamilton, GS; Steiner, JP
    The small molecule FKBP ligand GPI 1046 induces partial striatal re-innervation after intranigral 6-hydroxydopamine lesion in rats
    NEUROSCIENCE LETTERS
    
    D.T. Ross et al., "The small molecule FKBP ligand GPI 1046 induces partial striatal re-innervation after intranigral 6-hydroxydopamine lesion in rats", NEUROSCI L, 297(2), 2001, pp. 113-116
43. Ogawa, Y; Okamoto, S; Kuwana, M; Mori, T; Watanabe, R; Nakajima, T; Yamada, M; Mashima, Y; Tsubota, K; Oguchi, Y
    Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids
    CORNEA
    
    Y. Ogawa et al., "Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids", CORNEA, 20(4), 2001, pp. 430-434
44. Ierardi, E; Principi, M; Francavilla, R; Pisani, A; Rendina, M; Ingrosso, M; Guglielmi, FW; Panella, C; Francavilla, A
    Oral tacrolimus long-term therapy in patients with Crohn's disease and steroid resistance
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    
    E. Ierardi et al., "Oral tacrolimus long-term therapy in patients with Crohn's disease and steroid resistance", ALIM PHARM, 15(3), 2001, pp. 371-377
45. Jacobson, P; Ng, J; Ratanatharathorn, V; Uberti, J; Brundage, RC
    Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients
    BONE MARROW TRANSPLANTATION
    
    P. Jacobson et al., "Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients", BONE MAR TR, 28(8), 2001, pp. 753-758
46. Hiraoka, A; Ohashi, Y; Okamoto, S; Moriyama, Y; Nagao, T; Kodera, Y; Kanamaru, A; Dohy, H; Masaoka, T
    Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation
    BONE MARROW TRANSPLANTATION
    
    A. Hiraoka et al., "Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation", BONE MAR TR, 28(2), 2001, pp. 181-185
47. Yamada, T; Hashimoto, T; Sogawa, M; Kobayashi, S; Kaneda, K; Nakamura, S; Kuno, A; Sano, H; Ando, T; Kobayashi, S; Aoki, S; Nakazawa, T; Ohara, H; Nomura, T; Joh, T; Itoh, M
    Role of T cells in development of chronic pancreatitis in male Wistar Bonn/Kobori rats: effects of tacrolimus
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    
    T. Yamada et al., "Role of T cells in development of chronic pancreatitis in male Wistar Bonn/Kobori rats: effects of tacrolimus", AM J P-GAST, 281(6), 2001, pp. G1397-G1404
48. Bekersky, I; Fitzsimmons, W; Tanase, A; Maher, RM; Hodosh, E; Lawrence, I
    Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
    
    I. Bekersky et al., "Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis", J AM ACAD D, 44(1), 2001, pp. S17-S27
49. Zylber-Katz, E; Granot, E
    Abrupt increase of tacrolimus blood levels during an episode of Shigella infection in a child after liver transplantation
    THERAPEUTIC DRUG MONITORING
    
    E. Zylber-Katz e E. Granot, "Abrupt increase of tacrolimus blood levels during an episode of Shigella infection in a child after liver transplantation", THER DRUG M, 23(6), 2001, pp. 647-649
50. Ahmed, M; Venkataraman, R; Logar, AJ; Rao, AS; Bartley, GP; Robert, K; Dodson, FS; Shapiro, R; Fung, JJ; Zeevi, A
    Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-gamma inhibition in CD8(-) and CD8(+) peripheral blood T cells
    THERAPEUTIC DRUG MONITORING
    
    M. Ahmed et al., "Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-gamma inhibition in CD8(-) and CD8(+) peripheral blood T cells", THER DRUG M, 23(4), 2001, pp. 354-362
51. Lensmeyer, GL; Poquette, MA
    Therapeutic monitoring of tacrolimus concentrations in blood: Semi-automated extraction and liquid chromatography-electrospray ionization mass spectrometry
    THERAPEUTIC DRUG MONITORING
    
    G.L. Lensmeyer e M.A. Poquette, "Therapeutic monitoring of tacrolimus concentrations in blood: Semi-automated extraction and liquid chromatography-electrospray ionization mass spectrometry", THER DRUG M, 23(3), 2001, pp. 239-249
52. Macchi-Andanson, M; Charpiat, B; Jelliffe, RW; Ducerf, C; Fourcade, N; Baulieux, J
    Failure of traditional trough levels to predict tacrolimus concentrations
    THERAPEUTIC DRUG MONITORING
    
    M. Macchi-Andanson et al., "Failure of traditional trough levels to predict tacrolimus concentrations", THER DRUG M, 23(2), 2001, pp. 129-133
53. Sloper, CML; Powell, RJ; Dua, HS
    Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts
    OPHTHALMOLOGY
    
    C.M.L. Sloper et al., "Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts", OPHTHALMOL, 108(10), 2001, pp. 1838-1844
54. Scolapio, JS; Bowen, J; Lukens, FJ; Ukleja, A; Atkinson, E
    Influence of tacrolimus and prednisone on serum lipids after liver transplantation
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION
    
    J.S. Scolapio et al., "Influence of tacrolimus and prednisone on serum lipids after liver transplantation", J PARENT EN, 25(3), 2001, pp. 148-151
55. Copello, JA; Qi, Y; Jeyakumar, LH; Ogunbunmi, E; Fleischer, S
    Lack of effect of cADP-ribose and NAADP on the activity of skeletal muscleand heart ryanodine receptors
    CELL CALCIUM
    
    J.A. Copello et al., "Lack of effect of cADP-ribose and NAADP on the activity of skeletal muscleand heart ryanodine receptors", CELL CALC, 30(4), 2001, pp. 269-284
56. Zubrzak, P; Kaczmarek, K; Kowalski, ML; Szkudlinska, B; Zabrocki, J
    Search for new synthetic immunosuppressants. Antamanide analogues containing the tetrazole ring as a cis-peptide bond mimetic
    POLISH JOURNAL OF CHEMISTRY
    
    P. Zubrzak et al., "Search for new synthetic immunosuppressants. Antamanide analogues containing the tetrazole ring as a cis-peptide bond mimetic", POL J CHEM, 75(12), 2001, pp. 1869-1876
57. Chau, TN; Quaglia, A; Rolles, K; Burroughs, AK; Dhillon, AP
    Histological patterns of rejection using oral microemulsified cyclosporineand tacrolimus (FK506) as monotherapy induction after orthotopic liver transplantation
    LIVER
    
    T.N. Chau et al., "Histological patterns of rejection using oral microemulsified cyclosporineand tacrolimus (FK506) as monotherapy induction after orthotopic liver transplantation", LIVER, 21(5), 2001, pp. 329-334
58. Reitamo, S
    Tacrolimus: A new topical immunomodulatory therapy for atopic dermatitis
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    
    S. Reitamo, "Tacrolimus: A new topical immunomodulatory therapy for atopic dermatitis", J ALLERG CL, 107(3), 2001, pp. 445-448
59. Panhans-Gross, A; Novak, N; Kraft, S; Bieber, T
    Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506)
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    
    A. Panhans-Gross et al., "Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506)", J ALLERG CL, 107(2), 2001, pp. 345-352
60. Bekersky, I; Dressler, D; Alak, A; Boswell, G; Mekki, QA
    Comparative tacrolimus pharmacokinetics: Normal versus mildly hepatically impaired subjects
    JOURNAL OF CLINICAL PHARMACOLOGY
    
    I. Bekersky et al., "Comparative tacrolimus pharmacokinetics: Normal versus mildly hepatically impaired subjects", J CLIN PHAR, 41(6), 2001, pp. 628-635
61. Venkataramanan, R; Shaw, LM; Sarkozi, L; Mullins, R; Pirsch, J; MacFarlane, G; Scheller, D; Ersfeld, D; Frick, M; Fitzsimmons, WE; Virji, M; Jain, A; Brayman, KL; Shaked, A
    Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients
    JOURNAL OF CLINICAL PHARMACOLOGY
    
    R. Venkataramanan et al., "Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients", J CLIN PHAR, 41(5), 2001, pp. 542-551
62. Sakai, H; Takeuchi, Y; Kawano, H; Matsushita, H; Yamazoe, I; Sugimoto, T
    FK506 itself does not demonstrate neurotoxicity in the mouse brain
    ACTA HISTOCHEMICA ET CYTOCHEMICA
    
    H. Sakai et al., "FK506 itself does not demonstrate neurotoxicity in the mouse brain", ACT HIST CY, 34(5), 2001, pp. 349-355
63. Yu, CC; Kelly, PA; Burckart, GJ; Zeevi, A
    Sirolimus inhibition of lymphocyte proliferation is not antagonized by ciprofloxacin and other quinolone antibiotics
    TRANSPLANTATION PROCEEDINGS
    
    C.C. Yu et al., "Sirolimus inhibition of lymphocyte proliferation is not antagonized by ciprofloxacin and other quinolone antibiotics", TRANSPLAN P, 33(6), 2001, pp. 2989-2991
64. Weir, M
    Impact of immunosuppressive regimes on posttransplant diabetes mellitus
    TRANSPLANTATION PROCEEDINGS
    
    M. Weir, "Impact of immunosuppressive regimes on posttransplant diabetes mellitus", TRANSPLAN P, 33(5A), 2001, pp. 23S-26S
65. Marchetti, P
    Strategies for risk reduction and management of posttransplant diabetes mellitus
    TRANSPLANTATION PROCEEDINGS
    
    P. Marchetti, "Strategies for risk reduction and management of posttransplant diabetes mellitus", TRANSPLAN P, 33(5A), 2001, pp. 27S-31S
66. Chan, KL; Guo, WH; Tam, PKH
    Porcine small bowel transplantation with FK506 as a single immunosuppressant
    TRANSPLANTATION PROCEEDINGS
    
    K.L. Chan et al., "Porcine small bowel transplantation with FK506 as a single immunosuppressant", TRANSPLAN P, 33(4), 2001, pp. 2607-2608
67. Paul, LC
    Overview of side effects of immunosuppressive therapy
    TRANSPLANTATION PROCEEDINGS
    
    L.C. Paul, "Overview of side effects of immunosuppressive therapy", TRANSPLAN P, 33(3), 2001, pp. 2089-2091
68. Ierardi, E; Principi, M; Francavilla, R; Pisani, A; Rendina, M; Panella, C; Francavilla, A
    Long-term tacrolimus: A promising therapeutic approach for Crohn's disease
    TRANSPLANTATION PROCEEDINGS
    
    E. Ierardi et al., "Long-term tacrolimus: A promising therapeutic approach for Crohn's disease", TRANSPLAN P, 33(3), 2001, pp. 2107-2109
69. Wollenberg, A; Bieber, T
    Topical immunomodulatory agents and their targets in inflammatory skin diseases
    TRANSPLANTATION PROCEEDINGS
    
    A. Wollenberg e T. Bieber, "Topical immunomodulatory agents and their targets in inflammatory skin diseases", TRANSPLAN P, 33(3), 2001, pp. 2212-2216
70. Salizzoni, M; Cavallari, A; Risaliti, A; Filipponi, F; Gerunda, GE; Forti, D; Fassati, LR; Cillo, U; Castagneto, M; Valente, U; Tisone, G
    Tacrolimus-based dual therapy is as efficacious and safe as the conventional tacrolimus-based triple therapy in liver transplantation
    TRANSPLANTATION PROCEEDINGS
    
    M. Salizzoni et al., "Tacrolimus-based dual therapy is as efficacious and safe as the conventional tacrolimus-based triple therapy in liver transplantation", TRANSPLAN P, 33(3), 2001, pp. 2258-2262
71. Molinaro, M; Regazzi, MB; Pasquino, S; Rinaldi, M; Iacona, I; Campana, C; Vigano, M
    Pharmacokinetics of tacrolimus during the early phase after heart transplantation
    TRANSPLANTATION PROCEEDINGS
    
    M. Molinaro et al., "Pharmacokinetics of tacrolimus during the early phase after heart transplantation", TRANSPLAN P, 33(3), 2001, pp. 2386-2389
72. McCarter, JF; McGregor, AL; Jones, PA; Sharkey, J
    FK 506 protects brain tissue in animal models of stroke
    TRANSPLANTATION PROCEEDINGS
    
    J.F. McCarter et al., "FK 506 protects brain tissue in animal models of stroke", TRANSPLAN P, 33(3), 2001, pp. 2390-2392
73. van Gelder, T; Klupp, J; Sawamoto, T; Christians, U; Morris, RE
    ATP-binding cassette transporters and calcineurin inhibitors: Potential clinical implications
    TRANSPLANTATION PROCEEDINGS
    
    T. van Gelder et al., "ATP-binding cassette transporters and calcineurin inhibitors: Potential clinical implications", TRANSPLAN P, 33(3), 2001, pp. 2420-2421
74. Jiang, H; Yang, XF; Wynn, C; Soriano, R; Krishnan, K; Fujimura, T; Kobayashi, M
    IL-10: A tacrolimus-specific cytotoxic mediator in ongoing allograft rejection
    TRANSPLANTATION PROCEEDINGS
    
    H. Jiang et al., "IL-10: A tacrolimus-specific cytotoxic mediator in ongoing allograft rejection", TRANSPLAN P, 33(1-2), 2001, pp. 510-513
75. Orsenigo, R; Gatti, S; Latham, L; Trezza, P; Marelli, O
    FK506 and SMS 201-995: Effect on heterotopic heart transplantation in rats
    TRANSPLANTATION PROCEEDINGS
    
    R. Orsenigo et al., "FK506 and SMS 201-995: Effect on heterotopic heart transplantation in rats", TRANSPLAN P, 33(1-2), 2001, pp. 554-555
76. Erickson, LM; Yang, XF; Pan, F; Kobayashi, M; Jiang, H
    Gene expression profiles of rat heart allografts with immunosuppression
    TRANSPLANTATION PROCEEDINGS
    
    L.M. Erickson et al., "Gene expression profiles of rat heart allografts with immunosuppression", TRANSPLAN P, 33(1-2), 2001, pp. 562-566
77. Berloco, P; Rossi, M; Pretagostini, R; Cortesini, NSF; Cortesini, R
    Tacrolimus as cornerstone immunosuppressant in kidney transplantation
    TRANSPLANTATION PROCEEDINGS
    
    P. Berloco et al., "Tacrolimus as cornerstone immunosuppressant in kidney transplantation", TRANSPLAN P, 33(1-2), 2001, pp. 994-996
78. Abouljoud, M; Kumar, MSA; Brayman, K; Emre, S; Bynon, SJ
    Conversion to neoral provides effective rescue therapy for liver and kidney transplant patients intolerant of Prograf
    TRANSPLANTATION PROCEEDINGS
    
    M. Abouljoud et al., "Conversion to neoral provides effective rescue therapy for liver and kidney transplant patients intolerant of Prograf", TRANSPLAN P, 33(1-2), 2001, pp. 1027-1028
79. Dudley, CRK
    Conversion at first rejection: A prospective trial comparing cyclosporine microemulsion with tacrolimus in renal transplant recipients
    TRANSPLANTATION PROCEEDINGS
    
    C.R.K. Dudley, "Conversion at first rejection: A prospective trial comparing cyclosporine microemulsion with tacrolimus in renal transplant recipients", TRANSPLAN P, 33(1-2), 2001, pp. 1034-1035
80. Steinmuller, T; Stockmann, M; Jonas, S; Muller, A; Settmacher, U; Langrehr, J; Ulrich, F; Bechstein, WO; Neuhaus, P
    The impact of liver transplantation on diabetes mellitus
    TRANSPLANTATION PROCEEDINGS
    
    T. Steinmuller et al., "The impact of liver transplantation on diabetes mellitus", TRANSPLAN P, 33(1-2), 2001, pp. 1393-1393
81. Banerjee, R; Leaver, N; Lyster, H; Banner, NR
    Coadministration of itraconazole and tacrolimus after thoracic organ transplantation
    TRANSPLANTATION PROCEEDINGS
    
    R. Banerjee et al., "Coadministration of itraconazole and tacrolimus after thoracic organ transplantation", TRANSPLAN P, 33(1-2), 2001, pp. 1600-1602
82. Burke, GW; Ciancio, G; Olson, L; Roth, D; Miller, J
    Ten-year survival after simultaneous pancreas/kidney transplantation with bladder drainage and tacrolimus-based immunosuppression
    TRANSPLANTATION PROCEEDINGS
    
    G.W. Burke et al., "Ten-year survival after simultaneous pancreas/kidney transplantation with bladder drainage and tacrolimus-based immunosuppression", TRANSPLAN P, 33(1-2), 2001, pp. 1681-1683
83. Reimer, J; Franke, GH; Luetkes, P; Kohnle, M; Philipp, T; Heemann, U
    Quality of life after kidney transplantation - The impact of tacrolimus
    TRANSPLANTATION PROCEEDINGS
    
    J. Reimer et al., "Quality of life after kidney transplantation - The impact of tacrolimus", TRANSPLAN P, 33(1-2), 2001, pp. 1924-1926
84. Al-Uzri, A; Stablein, DM; Cohn, RA
    Posttransplant diabetes mellitus in pediatric renal transplant recipients:A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)
    TRANSPLANTATION
    
    A. Al-Uzri et al., "Posttransplant diabetes mellitus in pediatric renal transplant recipients:A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)", TRANSPLANT, 72(6), 2001, pp. 1020-1024
85. Staatz, CE; Taylor, PJ; Lynch, SV; Willis, C; Charles, BG; Tett, SE
    Population pharmacokinetics of tacrolimus in children who receive cut-downor full liver transplants
    TRANSPLANTATION
    
    C.E. Staatz et al., "Population pharmacokinetics of tacrolimus in children who receive cut-downor full liver transplants", TRANSPLANT, 72(6), 2001, pp. 1056-1061
86. Selzner, N; Durand, F; Bernuau, J; Heneghan, MA; Tuttle-Newhall, JE; Belghiti, J; Clavien, PA
    Conversion from cyclosporine to FK506 in adult liver transplant recipients: A combined North American and European experience
    TRANSPLANTATION
    
    N. Selzner et al., "Conversion from cyclosporine to FK506 in adult liver transplant recipients: A combined North American and European experience", TRANSPLANT, 72(6), 2001, pp. 1061-1065
87. Aharoni, R; Teitelbaum, D; Arnon, R; Sela, M
    Copolymer 1 inhibits manifestations of graft rejection
    TRANSPLANTATION
    
    R. Aharoni et al., "Copolymer 1 inhibits manifestations of graft rejection", TRANSPLANT, 72(4), 2001, pp. 598-605
88. Squifflet, JP; Backman, L; Claesson, K; Dietl, KH; Ekberg, H; Forsythe, JLR; Kunzendorf, U; Heemann, U; Land, W; Morales, JM; Muhlbacher, F; Talbot, D; Taube, D; Tyden, G; van Hooff, J; Schleibner, S; Vanrenterghem, Y
    Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients
    TRANSPLANTATION
    
    J.P. Squifflet et al., "Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients", TRANSPLANT, 72(1), 2001, pp. 63-69
89. Tuteja, S; Alloway, RR; Johnson, JA; Gaber, AO
    The effect of gut metabolism on tacrolimus bioavailability in renaltransplant recipients
    TRANSPLANTATION
    
    S. Tuteja et al., "The effect of gut metabolism on tacrolimus bioavailability in renaltransplant recipients", TRANSPLANT, 71(9), 2001, pp. 1303-1307
90. Jain, A; Kashyap, R; Marsh, W; Rohal, S; Khanna, A; Fung, JJ
    Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus
    TRANSPLANTATION
    
    A. Jain et al., "Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus", TRANSPLANT, 71(8), 2001, pp. 1102-1106
91. Paolillo, JA; Boyle, GJ; Law, YM; Miller, SA; Lawrence, K; Wagner, K; Pigula, FA; Griffith, BP; Webber, SA
    Posttransplant diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression
    TRANSPLANTATION
    
    J.A. Paolillo et al., "Posttransplant diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression", TRANSPLANT, 71(2), 2001, pp. 252-256
92. Lee, WPA; Rubin, JP; Bourget, JL; Cober, SR; Randolph, MA; Nielsen, GP; Ierino, FL; Sachs, DH
    Tolerance to limb tissue allografts between swine matched for major histocompatibility complex antigens
    PLASTIC AND RECONSTRUCTIVE SURGERY
    
    W.P.A. Lee et al., "Tolerance to limb tissue allografts between swine matched for major histocompatibility complex antigens", PLAS R SURG, 107(6), 2001, pp. 1482-1490
93. Jones, NF; Hebebrand, D; Buttemeyer, R; Zhao, M; Benhaim, P; Rao, U
    Comparison of long-term immunosuppression for limb transplantation using cyclosporine, tacrolimus, and mycophenolate mofetil: Implications for clinical composite tissue transplantation
    PLASTIC AND RECONSTRUCTIVE SURGERY
    
    N.F. Jones et al., "Comparison of long-term immunosuppression for limb transplantation using cyclosporine, tacrolimus, and mycophenolate mofetil: Implications for clinical composite tissue transplantation", PLAS R SURG, 107(3), 2001, pp. 777-784
94. Fukatsu, S; Yano, I; Igarashi, T; Hashida, T; Takayanagi, K; Saito, H; Uemoto, S; Kiuchi, T; Tanaka, K; Inui, K
    Population pharmacokinetics of tacrolimus in adult recipients receiving living-donor liver transplantation
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    
    S. Fukatsu et al., "Population pharmacokinetics of tacrolimus in adult recipients receiving living-donor liver transplantation", EUR J CL PH, 57(6-7), 2001, pp. 479-484
95. Furukawa, M; Terae, S; Chu, BC; Kaneko, K; Kamada, H; Miyasaka, K
    MRI in seven cases of tacrolimus (FK-506) encephalopathy: utility of FLAIRand diffusion-weighted imaging
    NEURORADIOLOGY
    
    M. Furukawa et al., "MRI in seven cases of tacrolimus (FK-506) encephalopathy: utility of FLAIRand diffusion-weighted imaging", NEURORADIOL, 43(8), 2001, pp. 615-621
96. Trimarchi, H; Freixas, E; Rabinovich, O; Schropp, J; Pereyra, H; Bullorsky, E
    Cyclosporine-associated thrombotic microangiopathy during daclizumab induction: A suggested therapeutic approach
    NEPHRON
    
    H. Trimarchi et al., "Cyclosporine-associated thrombotic microangiopathy during daclizumab induction: A suggested therapeutic approach", NEPHRON, 87(4), 2001, pp. 361-364
97. Laham, G; Vilches, A; Jost, L; Jost, L; Nogues, M
    Acute multifocal demyelinating peripheral neuropathy and acute renal failure after administration of FK 506.
    MEDICINA-BUENOS AIRES
    
    G. Laham et al., "Acute multifocal demyelinating peripheral neuropathy and acute renal failure after administration of FK 506.", MEDICINA, 61(4), 2001, pp. 445-446
98. Mayer, K; Reinhard, T; Reis, A; Bohringer, D; Sundmacher, R
    FK 506 ointment 0.1% - A new therapeutic option for atopic blepharitis. Clinical trial with 14 patients
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE
    
    K. Mayer et al., "FK 506 ointment 0.1% - A new therapeutic option for atopic blepharitis. Clinical trial with 14 patients", KLIN MONATS, 218(11), 2001, pp. 733-736
99. Arimoa, H; Yunomae, K; Hirayama, F; Uekama, K
    Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    H. Arimoa et al., "Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus", J PHARM EXP, 297(2), 2001, pp. 547-555
100. Arima, H; Yunomae, K; Miyake, K; Irie, T; Hirayama, F; Uekama, K
     Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats
     JOURNAL OF PHARMACEUTICAL SCIENCES
     
     H. Arima et al., "Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats", J PHARM SCI, 90(6), 2001, pp. 690-701